AI Applied to Genomics Is Heating Up


Samsung Electronics invested $175 million in Element Biosciences, a U.S. genetics company based in San Diego
The investment makes Samsung the company’s largest shareholder
Element makes gene-sequencing systems such as AVITI and VITARI, with upcoming products including AVITI Dx and AVITI24. These tools decode DNA and RNA and are used in areas such as medical research, disease detection, drug development, and diagnostics
Samsung wants to combine Element’s DNA sequencing and multi-omics technology with its own capabilities in AI, medical devices, and digital health. The goal is to pursue opportunities in personalized medicine and next-generation genetic diagnostics
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned